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Abstract
The apoptosis of cancer cells is associated with changes in the important cell properties including morphology, surface
roughness and stiffness. Therefore, the changes in morphology and biophysical properties can be a good way of evaluating
the anticancer activity of a drug. This study examined the effect of paclitaxel on the properties of Ishikawa and HeLa cells
using atomic force microscopy (AFM), and the relationship between the changes in morphology and the biophysical
properties and apoptosis was discussed. The viability and proliferation of the cells were analyzed using the methylthiazol
tetrazolium (MTT) method and a TUNEL assay to confirm cellular apoptosis due to a paclitaxel treatment. AFM observations
clearly showed the apoptotic morphological and biophysical changes in Ishikawa and HeLa cells. After the paclitaxel
treatment, the cell membrane was torn and holed, the surface roughness was increased, and the stiffness was decreased.
These changes were observed more apparently after a 24 h treatment and in Ishikawa cells compared to HeLa cells. The
MTT and TUNEL assays results revealed the Ishikawa cells to be more sensitive to paclitaxel than HeLa cells and definite
apoptosis occurred after a 24 h treatment. These results showed good agreement with the AFM results. Therefore, research
on the morphological and biophysical changes by AFM in cancer cells will help to evaluate the anticancer activities of the
drugs.
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Introduction
Paclitaxel is an antineoplastic agent that is commonly used in
the treatment of human carcinomas [1–6] and has shown
promising potential in the treatment of epithelial cancers, such
as breast, ovarian, lung and colon [1,2]. As a microtubule-
stabilizing agent, the mechanism of action of paclitaxel is
considered unique. The drug binds to the b-subunit of tubulin
in tumor cells and promotes the formation of stable microtubules.
As a result, the dynamic instability of cells decreases and the
microtubule rigidity increases, thereby inhibiting cell replication
through a disruption of normal mitotic spindle formation [1,2].
Additional activities of paclitaxel have been reported in a range of
tumor cells. Paclitaxel induces apoptosis, which is dependent upon
FAS-associated death domain protein through the activation of
caspase-10 but is independent of the death receptors [3]. In
addition, paclitaxel regulates the expression of the apoptosis-
related proteins, such as bcl-2, bad, bcl-xL, and tumor necrosis
factor 1 (TNF-a) [4–6]. However, the precise mechanism
underlying paclitaxel-induced apoptosis in different cell lines and
under different stimuli is unclear.
Recently, it was suggested that a study of the morphological and
biophysical changes in cancer cells treated with anticancer drugs
would help in evaluating the anticancer activity of a drug [7,8].
This was suggested in part because antimicrotubule drugs affect
the shape and physical properties of the cell, such as roughness and
stiffness, which are related to the cell functions of adherence,
motility, transformation and invasion. These changes in the
morphology and physical properties of individual cells can be
detected by atomic force microscopy (AFM). Since AFM is a very
high-resolution type of scanning probe microscopy, it has been
shown to be a powerful tool for imaging materials at the
nanometer level and for observing the ultrastructure of a cell
[9,10]. In particular, this method is appropriate for measuring the
changes in the biophysical properties of the cell [11,12]. This
research is in the forefront of the field, and few studies have
reported the morphological and physical properties of cancer cells
after an anticancer drug treatment.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30066This study evaluated the potential of AFM as a new method for
evaluating the anticancer activity of a drug. The effects of
paclitaxel on the morphology and biophysical properties of
Ishikawa and HeLa cells were examined by AFM. The cell
viability and apoptosis were observed using MTT and TUNEL
assays, respectively. A correlation was observed between the
changes in the morphology and the biophysical property and
apoptosis in the cancer cells. These results were discussed in
relation to the possible underlying mechanism of action of
paclitaxel.
Results
1. Effects of paclitaxel on cell viability as analyzed using
the MTT assay
The effects of paclitaxel on both Ishikawa and HeLa cells were
estimated using a MTT assay, which measures the metabolic
activity of the mitochondria. Figures 1(a) and (b) show the rates of
Ishikawa and HeLa cell proliferation as a function of the treatment
time at different paclitaxel concentrations (DMSO, 10, 25, 50, and
75 mM, respectively). In both cell types, the proliferation rates
were increased in DMSO but decreased in paclitaxel. In Ishikawa
cells, the proliferation rate decreased significantly in a time- and
concentration-dependent manner. The proliferation rates of the
Ishikawa cells treated with 10, 25, 50, and 75 mM paclitaxel were -
53, -36, -20, and -36% of the baseline, respectively. The assay was
performed twice in the same manner. After the MTT assay,
50 mM paclitaxel was used for the TUNEL assay.
2. TUNEL assay for apoptotic cells
To evaluate cell death, a TUNEL assay was performed in both
Ishikawa and HeLa cells treated with 50 mM paclitaxel for various
times (0, 12, 24, and 48 h). All cells were fixed in methanol.
Figures 2(A) and (B) show the results of the TUNEL assay of
Ishikawa and HeLa cells, respectively. In situ apoptosis detections
of TdT-Fluor in the control (0 h) and treatment groups (12, 24,
and 48 h) were compared to confirm apoptosis and quantify cell
death. The TUNEL assay showed more cell death in the treatment
groups compared to that in the control group. Large numbers of
reactive cells were present in the Ishikawa cells after a 24 h
treatment with paclitaxel and in Ishikawa cells after a 12 h
paclitaxel treatment. On the other hand, apoptotic cell death was
observed in both the Ishikawa and HeLa cells after 24 h of
paclitaxel treatment.
3. Morphological changes caused by paclitaxel
High-resolution AFM images were obtained for both Ishikawa
and HeLa cells fixed in 2.5% GA for 30 min to optimize the
imaging conditions. The cells were imaged in PBS buffer solution
to avoid any size and shape distortions that would otherwise be
caused by drying. Both cell types were treated with 50 mM
paclitaxel for various lengths of time. Figure 3 shows representa-
tive AFM images of both untreated (0 h) and treated Ishikawa cells
for 6, 12, 24, 36 and 48 h.
The untreated Ishikawa cells showed a conventional cellular
shape with distinct boundaries and centrally located nuclei. There
were no typical morphological changes after 6 h of treatment. On
the other hand, when the Ishikawa cells were exposed to paclitaxel
for more than 24 h, obvious apoptotic changes, such as
aggregation, micronucleated cells and floating cells, were ob-
served. Interestingly, the cell membranes were severely damaged.
The membrane of the untreated cell was smooth, as shown in
Fig. 3(aii), but was rough and torn after the paclitaxel treatment.
The damage became worse as the treatment increased, particu-
larly after 24 h treatment. In addition, the hole appeared on the
membrane surface after 12 h of treatment. The hole was small in
both number and size and was shallow in depth. The number and
depth of the holes increased with increasing treatment time.
Detailed information regarding the holes is listed in Table 1.
The height of the cell, which was defined as the difference
between the top and bottom of the cell, was determined from the
3D images. The height was changed by the paclitaxel treatment,
but there was no correlation between the treatment condition and
cell height. Table 1 lists the height of Ishikawa cells, which is the
averaged data determined from more than 5 cells for each group.
An analysis of the surface roughness provides novel quantitative
data for a study of the cancer cell morphology. Table 2 lists the
results of two surface roughness parameters, Ra and Rq,
determined in an area of 666 mm
2 and 363 mm
2. Both Ra and
Rq showed significant dependence on the paclitaxel treatment
conditions. The untreated cell showed the smallest Ra and Rq, as
expected by the smooth surface shown in Figs. 3(aii) and (aiv). In all
treated cells, Ra and Rq were more than double (after 24 h) that of
the untreated cells indicating a rougher surface, and the values
increased with increasing treatment time. The hole is one of source
of the rougher surface, as shown in Figs. 3(civ), (div), (eiv), and (fiv).
The change in roughness in all treated cells was significant
compare to the untreated cell.
Figure 4 shows AFM images of HeLa cells; full (first column),
magnified (second column), 3D images (third column) and line
Figure 1. Cell viabilities of Ishikawa (a) and HeLa (b) cells. The
cells were seeded (2610
5) and treated for various lengths of time
(0,48 h) with various concentrations (10,75 mM) of paclitaxel and
were analyzed using the MTT assay.
doi:10.1371/journal.pone.0030066.g001
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conditions as for the Ishikawa cells. The untreated HeLa cells were
almost circular in shape with a smooth edge. The morphological
changes induced by paclitaxel were similar to those observed in the
Ishikawa cells. The cells that has been treated for 6 h showed no
significant changes but cells treated for more than 12 h showed
damage to their cell membranes. Compared to the Ishikawa cells,
the membrane damage was less significant and the holes were
smaller in number and size and its depth was shallower, as shown
in Table 1. The mean height of the HeLa cells showed no
dependence on the paclitaxel treatment. The surface roughness of
HeLa cells was also increased by the paclitaxel treatment due to
the damaged morphology, but it was a gradual change compared
to the Ishikawa cells.
4. Effects of paclitaxel on cell membrane stiffness
The FD curve using AFM was obtained by measuring the
amount of cantilever deflection as the probe approaches or retracts
to the sample. Figure 5 shows the FD curves as a plot of the
change in force, which is the multiply cantilever deflection by the
spring constant of the cantilever, verses the probe position in the z-
direction. Figs. 5(a), (b) and (c) are the FD curves of the control,
treated Ishikawa (h=6) and HeLa (h=6) cells, respectively. The
open circle and open rectangle represent the loading and
unloading processes, respectively. The slop of the loading curve
gives the information about the cell stiffness. The slop was largest
in the control, and it decreased in both paclitaxel treated cells.
Figures 6(a) and (b) show the stiffness as a function of paclitaxel
treatment time in Ishikawa and HeLa cells, respectively. The stiffness
of the Ishikawa cells was significantly decreased by the paclitaxel
treatment. The stiffness of the cells treated for 6 h was only 35% of
that of the untreated cells. The stiffness decreased slightly at 12 h but
there was no significant change after 12 h. In the HeLa cells, different
changes in stiffnesswere observed. The stiffness of the treated cells for
6 and 12 h was larger than that of the untreated cell. In contrast, it
decreased by 43,67% for treatments longer than 24 h.
Discussion
Although paclitaxel has demonstrated a wide spectrum of
antineoplastic activity in a range of cancer cell types, the precise
mechanism of apoptosis is unclear [1–6]. In the present study, the
action of paclitaxel was examined by analyzing its effects on the
morphology and microphysical properties of Ishikawa and HeLa
cells. AFM showed that paclitaxel induced cell membrane damage
in both cells. The membrane was damaged significantly after a
24 h paclitaxel treatment and the damage was more severe in
Ishikawa cell than in HeLa cells. In both cells, the membrane was
softer and rougher in the treated cells compared to those in the
untreated cells. The MTT and TUNEL assays revealed the
Ishikawa cells to be more sensitive to paclitaxel than HeLa cells,
and the apoptosis was more apparent after 24 h treatment. These
results are similar to the AFM results.
The MTT and TUNEL assay results showed the inhibitory
effects of paclitaxel on cell proliferation according to the varying
concentrations and treatment times. According to these results,
although significant increases in TUNEL–positive cells appeared
in both Ishikawa and HeLa cells after 24 h, the Ishikawa cells were
more sensitive to paclitaxel than HeLa cells. This different
response to paclitaxel between the two cell lines might be a result
of the different organ originations and the extent of a reaction
according to the tumor type. The antiproliferative activity of
paclitaxel might be related to mitotic arrest or in part to either
cytotoxic properties or the apoptotic process due to micromolar
dosing [13–15]. The proliferation and apoptotic analyses suggest
that a treatment with paclitaxel promotes apoptotic cell death and
decreases in the proliferation of Ishikawa and HeLa cells.
Apoptosis is a physiological mode of cell death that removes
cells at a given time or in response to a given stimulus in the
absence of an inflammatory response. The process is defined by
the unique morphological and biomechanical characteristics
including cell shrinkage and nuclear condensation. Although
there have been other characteristics attributed to the apoptotic
process, the loss of volume or cell shrinkage is the single
Figure 2. Detection of DNA fragmentation in paclitaxel-treated Ishikawa (A) and HeLa (B) cells using the TUNEL assay.
doi:10.1371/journal.pone.0030066.g002
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cancer cells [16]. Cisplatin, which is one of the primary drugs used
in the treatment of cancers of the cervix, endometrium and
ovaries, induces two different modes of cell death, necrosis and
apoptosis [17]. Necrosis is characterized by cytosolic swelling and
the early loss of plasma-membrane integrity, whereas apoptosis
includes cell shrinkage and DNA fragmentation. Wang et al.
reported that human lung adenocarcinoma cells swelled due to the
paclitaxel treatment, resulting in increased cell height and
decreased surface roughness [11]. On the other hand, in the
paclitaxel-treated Ishikawa and HeLa cells, these characteristics of
necrosis and apoptosis, including swelling or shrinkage, had not
been observed previously [18]. In the present study, the typical
apoptotic process was not observed in all paclitaxel-treated cells.
Although the surface morphology of treated cells appear more
convoluted than those of the untreated cells, the membrane
surface still appears quite smooth and firm indicating no
shrinkage. In both cells, the surface roughness increased with
increasing treatment time but the cell heights did not showed any
dependency on the paclitaxel treatment. The increased roughness
can be understood by the damaged membrane not by cell
shrinkage. As mentioned previously, the surface roughness is
defined as the arithmetic mean of the deviations in height from the
mean value [12]. Therefore, the holes in the membrane surface
cause increased roughness, and the surface becomes rougher as the
holes become deeper.
The holes on the membrane caused by paclitaxel are quite
interesting but the mechanism is still unclear. The occurrence of
macroscopic holes may be not the main path of apoptosis but
could be the path of necrosis. Wang et. al. suggested that the holes
observed in human lung adenocarcinoma cells may have resulted
from paclitaxel-induced ER swelling, which was localized around
Figure 3. Representative AFM images from both untreated (0 h) and treated Ishikawa cells for 6, 12, 24, 36, and 48 h. The first and
second columns show full and magnified images (365 mm
2) of the cell. The third column shows a three dimensional (3D) image of the entire cell and
the fourth column is the line profile measured in the magnified image shown in the second column. The white line shows the position taken the line
profile. The colors in the images indicate different heights with light and dark colors corresponding to higher and lower topography, respectively.
doi:10.1371/journal.pone.0030066.g003
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holes were first observed after a 6 h paclitaxel treatment and the
large holes appeared around the nucleus after 12 h treatment.
Panayiotis et. al suggested that the holes appeared in the Ishikawa
cell as a result of a deficit of the lamina [2]. The lamina gap was
even observed in the cells in the process of exciting mitosis but
never detected in the untreated cells. In addition, the lamina
deficits were detected not only in cells treated with paclitaxel but
also in the cells treated with toxotere and vinorelbine. Another
way to produce holes on the membrane may be understood by the
mechanism of action of paclitaxel in cancer cells. Paclitaxel causes
damage to the mitotic spindle assembly, chromosome segregation
and cell division [19]. Ovarian cancer cells were treated with
paclitaxel resulted in the appearance of cytoplasmic vacuoles [20].
Paclitaxel can stabilize the microtubles, which results in an
enhancement of microtubule polymerization, and can protect
against microtubule disassembly and inhibit spindle formation in
mitosis [21,22]. The inhibited spindle functioning can suppress the
microtubule dynamics at low concentrations (5–30 nM), and
microtubule detachment from centrosomes can be suppressed at
higher concentrations (,0.2 mM) [23,24].
Recently, Sarah et al. performed an AFM study suggesting that
cancer cells are more than 70% softer than normal cells.
Therefore, the nanomechanical properties of a cell can be used
as a cancer-detection method [25]. Depending on this report, it
was assumed that the nanomechanical properties of the cancer cell
may also be changed by antineoplastic drugs. If so, these
properties will help in an evaluation of the anticancer activity of
a drug. As expected, the Ishikawa and HeLa cells treated with
paclitaxel were softer than the untreated cells, and the stiffness
decreased with increasing treatment time. In both cell types, the
paclitaxel treated cells were softer than the untreated cells except
for HeLa cells treated for 6 and 12 h. The elasticity of a cell is
related mainly to the intrinsic properties of the cell membrane and
components of the cytoskeleton, such as microtubules, intermedi-
ate fibers and actin fibers. According to Antin et al., paclitaxel
Table 1. Number of holes observed in the cell membrane along with their depths and the cell height as a function of the
paclitaxel treatment time in Ishikawa and HeLa cells.
Hole number (N/cell) Hole depth (mm) Cell height (mm)
Treatment time
(h) Ishikawa HeLa Ishikawa HeLa Ishikawa HeLa
0 0 0 0 0 4.1160.85 4.1560.70
6 0 0 0 0 3.2360.71 4.5861.32
12 8.766.70 8.0162.30 0.6360.21 0.6160.21 4.3561.48 4.4360.81
24 24.3166.10 26.01619.81 1.1360.59 0.4960.22 3.8160.87 3.3460.50
36 25.0167.10 14.0366.80 0.6560.39 0.8360.28 3.8460.14 3.8560.40
48 20.0164.10 13.0265.41 1.7260.95 0.7960.44 5.2461.22 4.4661.07
The hole and height were measured from 5,12 cells for each group and the results were normalized by the number of cell. The height of cell was defined as the largest
difference between the top and bottom of the cell.
doi:10.1371/journal.pone.0030066.t001
Table 2. The surface roughness parameters Ra and Rq as a function of the paclitaxel treatment time in Ishikawa and HeLa cells.
Ishikawa cell HeLa cell
Area
(mm
2)
Treatment
time (h) Ra (p-value) Rq (p-value) Ra (p-value) Rq (p-value)
666 0 71.6620.4 90.8625.4 92.9626.7 118.5634.5
6 114.2647.3 (,0.05) 144.3656.7 (,0.05) 141.7655.6 (0.02) 180.5671.9 (0.04)
12 136.1643.2 (,0.05) 173.7651.9 (,0.05) 122.1637.9 (0.32) 157.9650.6 (0.14)
24 193.96102.9 (,0.05) 247.76122.4 (,0.05) 97.9620.6 (0.23) 118.5628.7 (0.04)
36 201.4667.8 (,0.05) 259.8683.9 (,0.05) 111.3636.3 (,0.05) 148.3647.9 (,0.05)
48 245.8687.5 (,0.05) 306.56100.9 (,0.05) 180.1661.4 (,0.05) 229.2675.1 (,0.05)
363 0 66.4626.8 85.5634.5 79.9623.9 103.3631.8
6 115.1672.9 (,0.05) 144.9683.2 (,0.05) 96.5632.4 (0.02) 123.5642.2 (0.03)
12 103.6643.7 (,0.05) 142.9657.1 (,0.05) 89.6637.8 (0.37) 116.2645.1 (0.13)
24 125.9654.8 (,0.05) 161.9672.4 (,0.05) 88.2636.8 (0.26) 131.9680.4 (0.04)
36 161.9666.3 (,0.05) 209.4684.1 (,0.05) 127.7638.9 (,0.05) 157.3646.1 (,0.05)
48 178.5657.4 (,0.05) 218.8674.6 (,0.05) 168.3639.5 (,0.05) 216.1650.5 (,0.05)
The roughness was analyzed in two randomly selected small areas of 666 mm
2 and 363 mm
2 to avoid any artifact caused by the cell structure. P value corresponds to
the statistical results between the control (0 h) and the paclitaxel treated cells (6 h–48 h).
P-value is the statistical result between the nontreated cell and taxol treated cell.
doi:10.1371/journal.pone.0030066.t002
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from interdigitation in microtubule-myosin arrays [26]. Owing to
the paclitaxel treatment, the amounts of b-actin and laminin were
reduced and the intensities of fibronectin and laminin in the cells
was also reduced [27,28]. Therefore, the changes in cell stiffness
show good agreement with the paclitaxel-mediated activation of
apoptosis in both cells.
In summary, this is the first report of an investigation of AFM-
detected apoptotic morphological and biophysical changes in
Ishikawa and HeLa cells after a paclitaxel treatment. Apoptotic
cell death was induced by a paclitaxel treatment in both cell types.
AFM was used to evaluate quantitatively the morphological
changes in the cancer cells treated with paclitaxel. The changes in
cell rigidity caused by paclitaxel were also revealed using FD curve
measurements. The cell viability and apoptosis analyzed by a
MTT and TUNEL assay showed good agreement with the AFM
results. In conclusion, this study suggests that a study of the
morphological and biophysical changes in cancer cells using AFM
could be a potential method for evaluating the anticancer activity
of a drug.
Materials and Methods
1. Cells culture and treatments
Ishikawa cells was derived from well-differentiated human
endometrial epithelial adenocarcinomas cell line(99040201;
ECACC, UK) and grown in Minimum Essential Medium (Gibco,
Auckland, New Zealand) containing 5% FBS (Sigma, USA),
antibiotics (100 U/ml 122 of penicillin and 100 mg/ml of
streptomycin) and 2 mM glutamate. HeLa cell was derived from
human cervical cancer cell(KCLB-10002; KCLB, Korea), main-
tained in RPMI 1640 (WelGENE, Daegu, S. Korea) supplement-
ed with 10% fetal bovine serum (Sigma, USA) and cultured on
plastic substrata (SPL, USA) in a humidified 5% CO2 atmosphere
Figure 4. Representative AFM images from both untreated (0 h) and treated HeLa cells for 6, 12, 24, 36, and 48 h. The first and second
columns show full and magnified images (365 mm
2) of the cell. The third column shows a 3D image of the entire cell and the fourth column is the
line profile measured in the magnified image shown in the second column. The white line shows the position of the line profile. The colors in the
images indicate different heights with the light and dark colors corresponding to a higher and lower topography, respectively.
doi:10.1371/journal.pone.0030066.g004
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5) were seeded in dishes. Paclitaxel diluted
in DMSO (dimethyl sulfoxide) was applied at 37uC for four
different times. After the treatment, the cells were rinsed with
serum-free medium, incubated for 2 h, and fixed.
2. Sample fixation
The cells were fixed by immersion in 2.5% gluteraldehyde for
1 hour for the AFM measurement or for 1 hour in methanol for
the TUNEL assay. The cells were then rinsed three times with
PBS and stored at room temperature in the dark.
3. MTT assay
The cell viability and proliferation were analyzed using a
methylthiazol tetrazolium (MTT) assay. The colorimetric assay is
based on the ability of live cells to reduce the yellow MTT reagent
(Sigma, St Louis, MO, USA) to a purple formazan product. The
cells were seeded in 12 wells (SPL, Tissue Culture Testplate) at
various times (0, 6, 12, 24, and 48 h) and treated with paclitaxel
(P4394, Sigma, USA) at various doses (10, 25, 50, and 75 mM). A
total of 100 ml of a MTT solution was added to each well, and the
cells were then incubated at 37uC and 5% CO2 for 1 h. After
incubation, MTT was aspirated and 100 ml per well of DMSO
was added to each well. Subsequently, the cell viability was
assessed by measuring the absorbance at 540 nm.
4. TUNEL assay
For the detection of neuronal apoptosis, the terminal deox-
ynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling
(TUNEL) assay was performed in both Ishikawa and HeLa cells
using a commercial kit (TACSH 2 TdT-Fluor In Situ Apoptosis
Detection Kit) according to the manufacturer’s instructions.
Briefly, the cells were immersion hydrated, and the fixed and
immobilized samples were rinsed with a PBS solution for
10 minutes. The samples were pre-incubated with a 2% proteinase
K solution for 15 minutes at room temperature before being
incubated in a TdT labeling buffer for 5 minutes and with a
labeling reaction mix for 60 minutes in a humidity chamber. After
the cells were washed with PBS (0.05%), they were incubated for
30 min in the dark with a Strep-Fluor solution. After an additional
washing period, the tissues were covered with a DAPI mounting
medium (Vector, #H-1200) and analyzed by fluorescence
microscopy with a 495 nm filter.
5. Atomic force microscopy
The AFM system, NANOStation II (Surface Imaging Systems,
Herzogenrath, Germany), consisted of an AFM scanner and Zeiss
Figure 5. Force distance curve for control (a), treated Ishikawa
(b) and HeLa (c) cells. The force of cantilever was plotted as a
function of the probe position in the z-direction. The open circle and
rectangle show the loading and unloading processes, respectively. The
loading curve after the AFM tip approached closely or contacted the
sample surface, which gives the information of the sample property.
doi:10.1371/journal.pone.0030066.g005
Figure 6. Cell membrane stiffness as a function of the
paclitaxel treatment time in Ishikawa (a) and HeLa cells (b).
doi:10.1371/journal.pone.0030066.g006
AFM-Detected Apoptotic Changes Cancer Cells
PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30066optical microscope (Epiplan 5006). The cancer cell images were
measured with a reflex-coated gold cantilever in contact mode
(Budget Sensor, Bulgaria). The material properties and dimensions
of the probe used in contact mode were as follows: resonance
frequency of 13 kHz (64 kHz), force constant of 0.2 N/m
(60.14 N/m), cantilever length of 450 mm( 610 mm), cantilever
width of 38 mm( 65 mm), cantilever thickness of 2 mm( 61 mm),
tip radius of 5 nm (61 nm), and tip height of 17 mm( 62 mm). All
images were taken in a PBS buffer solution at a resolution of
2566256 pixels and a scan speed of 0.2 line/s. The scan area
depended on the size of the cancer cell and ranged from
40640,60660 mm
2. To minimize the elastic effects in the high-
resolution images, the samples were scanned at a low imaging
force of ,2 nN [29]. Image processing and data analysis were
performed using SPIPTM software (Scanning Probe Image
Processor version 4.1, Image Metrology, Denmark).
6. Surface roughness
The mean surface roughness (Ra) is defined as the arithmetic
mean of the deviations in height from the line mean value, and Rq
is the root mean square [12]. Since the roughness has a
dependence on the sampling size, Ra and Rq were calculated
for two different areas: 15 randomly selected 36 mm
2 (666 mm
2)
and 20 randomly selected 9 mm
2 (363 mm
2) sections of the cell
membrane. The holes were included in the roughness measure-
ment. Statistical analysis using a two-tailed Student’s t-test was
applied to all pairs of samples (untreated-treated cells) to determine
the significant differences in Ra and Rq. P-values,0.05 were
considered significant.
7. Stiffness
The cell stiffness was examined using the force-distance curve
(FD) obtained by measuring the amount of cantilever deflection as
the probe was approached or retracted from the sample. The
sample surface image was first scanned to determine the
appropriate site for the FD curve without defects or impurities.
The FD curves were measured in contact mode using the same
cantilever as used for the image scan. To reduce the error
originating from the cantilever and tip, all measurements were
performed using the probes manufactured under the same
conditions. The FD curve was measured more than 40 times per
cell, more than 150 times for each treated groups. The loading
rate of the probe was 1 mm/s. The slope of the FD curve after
contact (approaching the curve) was used to determine the stiffness
of the cell. To quantify the cell stiffness, the cellular spring constant
of kcell was calculated by modeling the cell-tip interaction as two
springs [30] as follows:
1
kcell
~
1
keffective
{
1
kcantilever
ð1Þ
where keffective is the slope of the linear region of the FD curve for a
cell, and kcantilever is determined from each cantilever using a clean
culture dish containing PBS.
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